Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peganum harmala L.’s anti-growth effect on a breast cancer cell line
Somayeh Hashemi Sheikh Shabani, Sahar Tehrani, Zohreh Rabiei, et al.
Biotechnology Reports (2015) Vol. 8, pp. 138-143
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

A review on traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the genus Peganum
Shuping Li, Xuemei Cheng, Changhong Wang
Journal of Ethnopharmacology (2017) Vol. 203, pp. 127-162
Closed Access | Times Cited: 112
Harmine induces anticancer activity in breast cancer cells via targeting TAZ
Yu Ding, Jinrong He, Juan Huang, et al.
International Journal of Oncology (2019)
Open Access | Times Cited: 60
Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment
Morena Miciaccia, Francesca Rizzo, Antonella Centonze, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 1, pp. 135-135
Open Access | Times Cited: 7
Synthesis of silver nanoparticles using Peganum harmala extract as a green route
Matin Azizi, Sajjad Sedaghat, Kambiz Tahvildari, et al.
Green Chemistry Letters and Reviews (2017) Vol. 10, Iss. 4, pp. 420-427
Open Access | Times Cited: 61
In vitro and in vivo activity of Peganum harmala L. alkaloids against phytopathogenic bacteria
Hanan A. Shaheen, Marwa Y. Issa
Scientia Horticulturae (2019) Vol. 264, pp. 108940-108940
Closed Access | Times Cited: 50
Discovery of Harmaline as a Potent Inhibitor of Sphingosine Kinase-1: A Chemopreventive Role in Lung Cancer
Sonam Roy, Taj Mohammad, Preeti Gupta, et al.
ACS Omega (2020) Vol. 5, Iss. 34, pp. 21550-21560
Open Access | Times Cited: 47
Improving health benefits with considering traditional and modern health benefits of Peganum harmala
Mohamad Hesam Shahrajabian, Wenli Sun, Qi Cheng
Clinical Phytoscience (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 36
Evaluation of the cytotoxic and cytostatic activities of alkaloid extracts from different parts of Peganum harmala L. (Zygophyllaceae)
Lamine Bournine, Sihem Bensalem, Sofiane Fatmi, et al.
European Journal of Integrative Medicine (2016) Vol. 9, pp. 91-96
Closed Access | Times Cited: 44
Harmaline induces apoptosis and inhibits migration in A2780 ovarian cancer cells in vitro
Seyed Ali Shariat Razavi, Masoumeh Taghdisi Khaboushan, Raha Jafari, et al.
Physiological Reports (2024) Vol. 12, Iss. 6
Open Access | Times Cited: 4
Peganum harmala Alkaloids Self-Assembled Supramolecular Nanocapsules with Enhanced Antioxidant and Cytotoxic Activities
Sherif Ashraf Fahmy, Marwa Y. Issa, Basma M. Saleh, et al.
ACS Omega (2021) Vol. 6, Iss. 18, pp. 11954-11963
Open Access | Times Cited: 27
Harmaline exerts potentially anti-cancer effects on U-87 human malignant glioblastoma cells in vitro
Mohammad Mahdi Vahedi, Ali Shahini, Mehran Mottahedi, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 5, pp. 4357-4366
Closed Access | Times Cited: 10
In vitro relationship between serum protein binding to beta-carboline alkaloids: a comparative cytotoxic, spectroscopic and calorimetric assays
Tapas Ghosh, Sarita Sarkar, Paromita Bhattacharjee, et al.
Journal of Biomolecular Structure and Dynamics (2019) Vol. 38, Iss. 4, pp. 1103-1118
Closed Access | Times Cited: 26
Alkaloids of Peganum harmala: Anticancer Biomarkers with Promising Outcomes
Atefeh Jalali, Farid Dabaghian, Mohammad M. Zarshenas
Current Pharmaceutical Design (2020) Vol. 27, Iss. 2, pp. 185-196
Closed Access | Times Cited: 25
Design, synthesis, and anti-proliferative evaluation of 1H-1,2,3-triazole grafted tetrahydro-β-carboline-chalcone/ferrocenylchalcone conjugates in estrogen responsive and triple negative breast cancer cells
Bharvi Sharma, Liang Gu, Ruvesh Pascal Pillay, et al.
New Journal of Chemistry (2020) Vol. 44, Iss. 26, pp. 11137-11147
Closed Access | Times Cited: 23
Peganum spp.: A Comprehensive Review on Bioactivities and Health-Enhancing Effects and Their Potential for the Formulation of Functional Foods and Pharmaceutical Drugs
Javad Sharifi‐Rad, Cristina Quispe, Jesús Herrera‐Bravo, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 20
Peganum harmala Extract Has Antiamoebic Activity to Acanthamoeba triangularis Trophozoites and Changes Expression of Autophagy-Related Genes
Rachasak Boonhok, Suthinee Sangkanu, Julalak Chuprom, et al.
Pathogens (2021) Vol. 10, Iss. 7, pp. 842-842
Open Access | Times Cited: 20
Insights into free radicals scavenging, α-Amylase inhibition, cytotoxic and antifibrotic activities unveiled by Peganum harmala extracts
Nidal Jaradat, Mohammed Hawash, Majid Sharifi‐Rad, et al.
BMC Complementary Medicine and Therapies (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Harmaline downregulates angiogenesis markers and suppresses the growth of 4T1 breast cancer cells in vivo and in vitro
Mohsen Rashidi, Elham Mahmoudian, Sepideh Mirzaei, et al.
Chemico-Biological Interactions (2022) Vol. 365, pp. 110087-110087
Closed Access | Times Cited: 11
Nedaplatin/Peganum harmala Alkaloids Co-Loaded Electrospun, Implantable Nanofibers: A Chemopreventive Nano-Delivery System for Treating and Preventing Breast Cancer Recurrence after Tumorectomy
Nada K. Sedky, Reem K. Arafa, Manal M. M. Abdelhady, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2367-2367
Open Access | Times Cited: 6
Anticancer Activity of <i>Peganum harmala</i> and <i>Haloxylon salicornicum</i> Leaf Extracts on Lung Cancer A549 and Prostate Cancer PC-3 Cell Lines
Naif M. Alhawiti, Waeel H. Alramadhan, William Boadi, et al.
American Journal of Plant Sciences (2023) Vol. 14, Iss. 11, pp. 1360-1374
Open Access | Times Cited: 6
Binding affinity and in vitro cytotoxicity of harmaline targeting different motifs of nucleic acids: An ultimate drug designing approach
Paromita Bhattacharjee, Tapas Ghosh, Sarita Sarkar, et al.
Journal of Molecular Recognition (2017) Vol. 31, Iss. 4
Closed Access | Times Cited: 14
Harmine and its derivatives: Biological activities and therapeutic potential in human diseases
Maria Javeed, Azhar Rasul, Ghulam Hussain, et al.
Bangladesh Journal of Pharmacology (2018) Vol. 13, Iss. 3, pp. 203-203
Open Access | Times Cited: 13
Trifluoromethylated carboline compounds targeting DNA: Synthesis, binding and anti-proliferative effects on human cancer cell lines
Sarita Sarkar, Olga I. Shmatova, Valentine G. Nenajdenko, et al.
Bioorganic Chemistry (2019) Vol. 86, pp. 61-79
Closed Access | Times Cited: 11
Cytotoxicity of alkaloids isolated from Peganum harmala seeds on HCT116 human colon cancer cells
Zahra Salimizadeh, Sattar Tahmasebi Enferadi, Tayebeh Majidizadeh, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top